News | December 29, 2014

Limit Imaging Scans for Headaches? Neurosurgeons Raise Concerns

A headache is sometimes the only symptom of brain tumors says report in Neurosurgery

CT systems, Clinical trial/study, neuroimaging tests

Image courtesy of Barco

December 29, 2014 — Recent guidelines seeking to reduce the use of neuroimaging tests for patients with headaches run the risk of missing or delaying the diagnosis of brain tumors, according to an article in Neurosurgery.

Neurosurgeon Dr. Ammar H. Hawasli and colleagues of Washington University School of Medicine, St. Louis, gave their perspective on recent guidelines suggesting limited use of CT scans and other neuroimaging tests for patients with headache.
Reducing the use of neuroimaging for patients with headaches has been one focus of recent initiatives seeking to limit the use of unnecessary and costly medical tests.

Several groups have proposed guidelines to limit the neuroimaging for headaches. For example, the "Choosing Wisely" guidelines developed by the American College of Radiology and Consumer Reports, include the recommendation, "Do not do imaging for uncomplicated headaches"—that is, most common types of stable headache, without any neurological abnormalities. A series of 95 patients with a confirmed diagnosis of a brain tumor at their department were analyzed. Nearly half of the patients had a combination of symptoms, such as seizures, cognitive and speech dysfunction or other neurological abnormalities. However, about one-fourth had isolated headaches, no symptoms or nonspecific symptoms.

In 11 patients, a headache was the only symptom of a brain tumor. Four of these patients had new-onset headaches that would have qualified them for neuroimaging under recently proposed guidelines.

The remaining seven patients had a migraine or other types of headache for which imaging may not have been performed under the proposed "Choosing Wisely" guidelines. Depending on which set of recent recommendations had been followed neuroimaging would have been delayed or never performed in 3-7 percent of patients with brain tumors.

That could have important implications for patient outcomes, as early diagnosis of brain tumors enables prompt treatment and a wider range of surgical options.

Authors of the study highlight the need for further research to develop "accurate and viable" guidelines on neuroimaging for headaches.

For more information: www.journals.lww.com/neurosurgery/pages/default.aspx

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Report Finds Identifying Patients for Lung Cancer Screening Not So Simple
News | Lung Cancer | June 18, 2018
New findings in the current issue of The American Journal of Managed Care suggest that getting the right patients to...
Weight-Bearing CT International Study Group Hosts  Scientific Session at AOFAS Conference
News | Computed Tomography (CT) | June 15, 2018
June 15, 2018 —The Weight-Bearing CT International Study Group will host a scientific session on the benefits of weig
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
360 Photos | 360 View Photos | June 14, 2018
This is a 360 degree image from the Canon Aquilion 64-slice...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
American Society of Neuroradiology Honors Peter Chang with Cornelius G. Dyke Memorial Award
News | Neuro Imaging | June 13, 2018
Peter Chang, M.D., current neuroradiology fellow at UCSF and recently recruited co-director of the UCI Center for...
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
Overlay Init